These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35587600)

  • 1. Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease.
    Laster ML; Rowan B; Chen HC; Schwantes-An TH; Sheng X; Friedman PA; Ikizler TA; Sinshiemer JS; Ix JH; Susztak K; de Boer IH; Kestenbaum B; Hung A; Moe SM; Perwad F; Robinson-Cohen C
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3866-e3876. PubMed ID: 35587600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T; Cai X; Lee J; Mehta R; Zhang X; Yang W; Nessel L; Anderson AH; Lo J; Porter A; Nunes JW; Negrea L; Hamm L; Horwitz E; Chen J; Scialla JJ; de Boer IH; Leonard MB; Feldman HI; Wolf M;
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between single nucleotide polymorphisms in the calcium sensing receptor and chronic kidney disease-mineral and bone disorder in cats.
    Geddes RF; Jepson RE; Forcada Y; Elliott J; Syme HM
    Vet J; 2018 May; 235():34-41. PubMed ID: 29704936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Variants Associated with Circulating Parathyroid Hormone.
    Robinson-Cohen C; Lutsey PL; Kleber ME; Nielson CM; Mitchell BD; Bis JC; Eny KM; Portas L; Eriksson J; Lorentzon M; Koller DL; Milaneschi Y; Teumer A; Pilz S; Nethander M; Selvin E; Tang W; Weng LC; Wong HS; Lai D; Peacock M; Hannemann A; Völker U; Homuth G; Nauk M; Murgia F; Pattee JW; Orwoll E; Zmuda JM; Riancho JA; Wolf M; Williams F; Penninx B; Econs MJ; Ryan KA; Ohlsson C; Paterson AD; Psaty BM; Siscovick DS; Rotter JI; Pirastu M; Streeten E; März W; Fox C; Coresh J; Wallaschofski H; Pankow JS; de Boer IH; Kestenbaum B
    J Am Soc Nephrol; 2017 May; 28(5):1553-1565. PubMed ID: 27927781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
    Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
    J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy.
    Gutiérrez OM
    J Ren Nutr; 2013 May; 23(3):250-4. PubMed ID: 23611556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
    J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disordered FGF23 and mineral metabolism in children with CKD.
    Portale AA; Wolf M; Jüppner H; Messinger S; Kumar J; Wesseling-Perry K; Schwartz GJ; Furth SL; Warady BA; Salusky IB
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):344-53. PubMed ID: 24311704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.
    Wahl P; Xie H; Scialla J; Anderson CA; Bellovich K; Brecklin C; Chen J; Feldman H; Gutierrez OM; Lash J; Leonard MB; Negrea L; Rosas SE; Anderson AH; Townsend RR; Wolf M; Isakova T;
    Diabetes Care; 2012 May; 35(5):994-1001. PubMed ID: 22446176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tubular reabsorption of phosphate as a surrogate marker for phosphate regulation in chronic kidney disease.
    Hong YA; Lim JH; Kim MY; Kim Y; Yang KS; Chung BH; Chung S; Choi BS; Yang CW; Kim YS; Chang YS; Park CW
    Clin Exp Nephrol; 2015 Apr; 19(2):208-15. PubMed ID: 24682550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CKD-MBD biomarkers and CKD progression: an analysis by the joint model.
    D'Arrigo G; Mallamaci F; Pizzini P; Leonardis D; Tripepi G; Zoccali C
    Nephrol Dial Transplant; 2023 Mar; 38(4):932-938. PubMed ID: 35790138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.
    Robinson-Cohen C; Bartz TM; Lai D; Ikizler TA; Peacock M; Imel EA; Michos ED; Foroud TM; Akesson K; Taylor KD; Malmgren L; Matsushita K; Nethander M; Eriksson J; Ohlsson C; Mellström D; Wolf M; Ljunggren O; McGuigan F; Rotter JI; Karlsson M; Econs MJ; Ix JH; Lutsey PL; Psaty BM; de Boer IH; Kestenbaum BR
    J Am Soc Nephrol; 2018 Oct; 29(10):2583-2592. PubMed ID: 30217807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C; Molnar MZ; Czira ME; Rosivall L; Kiss I; Remport A; Szathmari M; Mucsi I
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
    Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
    Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral metabolites and CKD progression in African Americans.
    Scialla JJ; Astor BC; Isakova T; Xie H; Appel LJ; Wolf M
    J Am Soc Nephrol; 2013 Jan; 24(1):125-35. PubMed ID: 23243213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?
    Evenepoel P; Rodriguez M; Ketteler M
    Semin Nephrol; 2014 Mar; 34(2):151-63. PubMed ID: 24780470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ; Harjes LM; Dembek K; Young GS; Chew DJ; Toribio RE
    J Vet Intern Med; 2017 May; 31(3):791-798. PubMed ID: 28186657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Graciolli FG; Neves KR; Barreto F; Barreto DV; Dos Reis LM; Canziani ME; Sabbagh Y; Carvalho AB; Jorgetti V; Elias RM; Schiavi S; Moysés RMA
    Kidney Int; 2017 Jun; 91(6):1436-1446. PubMed ID: 28318623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.